[Ataractic treatment in psychiatry and general medicine. Drug overview 10].
D014150:Antipsychotic Agents / Q000627:therapeutic use; D002090:Butyrophenones / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008615:Mephenesin / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D008803:Mianserin / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D002090:Butyrophenones; D014149:Tranquilizing Agents; D008803:Mianserin; D008615:Mephenesin; D008620:Meprobamate; C008522:metylperon; C005209:moperone
Die ataraktische Behandlung in Psychiatrie und Allgemeinmedizin. Präparate-Ubersicht, Folge 10.